Protoporphyrin IX plasma and blood pharmacokinetics and brain tumor distribution determined by a validated LC–MS/MS method
Abstract Protoporphyrin IX (PPIX) is a fluorescent metabolite in the heme biosynthesis pathway, and cancer cells accumulate it when 5-aminolevulinic acid (5-ALA), a precursor, is administered. In the U.S., 5-ALA is approved for visualizing high-grade gliomas (HGG) during fluorescence-guided surgery....
Saved in:
| Main Authors: | William Knight, Tigran Margaryan, Kamal Shaik, Nader Sanai, Artak Tovmasyan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05780-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sonodynamic Therapy Using 5-Aminolevulinic Acid for Malignant Gliomas: A Review
by: Andrea Ebeling, et al.
Published: (2025-04-01) -
Titanium-protoporphyrin IX coordinated nanoparticles for tumor photodynamic and sonodynamic combination therapy
by: Wei Wang, et al.
Published: (2025-05-01) -
The role of membrane transport proteins in 5-ALA-induced accumulation of protoporphyrin iX in tumor cells
by: V. I. Ivanova-Radkevich, et al.
Published: (2024-07-01) -
Investigation of the solubility of protoporphyrin IX in aqueous and hydroalcoholic solvent systems
by: Michelly de Sá Matsuoka, et al.
Published: (2025-07-01) -
Efficacy of photodynamic therapy using 5-aminolevulinic acid-induced photosensitization is enhanced in pancreatic cancer cells with acquired drug resistance
by: Yiran Liu, et al.
Published: (2024-12-01)